Sign In
Buy CLOV
$4.27
-0.0600 (-1.39%)
At Close: Aug 04, 2026
Clover Health Appoints Industry Veteran as Chief Medical Officer of Medicare Advantage
04:05pm, Monday, 07'th Apr 2025
Dr. Shelly Gupta Brings Over a Decade of Medicare Advantage and Healthcare Leadership Experience Dr. Shelly Gupta Brings Over a Decade of Medicare Advantage and Healthcare Leadership Experience
Clover Health: Expected Margin Contraction Is A Prelude To Exponential Growth
07:45am, Friday, 07'th Mar 2025
Clover Health Investments' AI capabilities are a major driver for its topline and bottom-line improvements in FY 2024. Clover Health's MCR in Q4 represented a decline from Q3, unlike past years, and r
Missed the Hims & Hers Rally? Clover Health Could Be Next
07:24am, Wednesday, 05'th Mar 2025
Shares of Hims & Hers Health Inc. NYSE: HIMS have made a splash in recent weeks, reaching a new all-time high of just under $73 per share. However, a few days later, most of the upside moved right ba
Counterpart Health Partners with Google Cloud to Improve Clinical Data Access for Physicians
09:00am, Monday, 03'rd Mar 2025
New functionality within Counterpart Assistant uses Google Cloud's Vertex AI Search to give clinicians comprehensive insights across multiple sources of patient health data New functionality within Co
CLOV Q4 Earnings Beat Estimates, Sales Miss, Membership Rises
10:40am, Friday, 28'th Feb 2025
Clover Health's fourth-quarter 2024 results continue to benefit from the strength of its strong member retention. Strong revenue outlook bodes well.
Clover Health Investments, Corp. (CLOV) Q4 2024 Earnings Call Transcript
07:32pm, Thursday, 27'th Feb 2025
Clover Health Investments, Corp. (NASDAQ:CLOV ) Q4 2024 Earnings Conference Call February 27, 2025 5:00 PM ET Company Participants Ryan Schmidt - Investor Relations Andrew Toy - Chief Executive Office
Clover Health Investments, Corp. (CLOV) Tops Q4 Earnings Estimates
07:30pm, Thursday, 27'th Feb 2025
Clover Health Investments, Corp. (CLOV) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.07 per share. This compares to loss of $0.12 per share
Clover Health Reports Fourth Quarter and Full Year 2024 Results; Provides Full Year 2025 Guidance
04:05pm, Thursday, 27'th Feb 2025
Full year 2024 GAAP Net loss from continuing operations improves by $164 million year-over-year Full year 2024 Adjusted EBITDA of $70 million, representing an increase of $112 million year-over-yea
Clover Health to Participate in Upcoming Investor Conferences
04:05pm, Monday, 24'th Feb 2025
WILMINGTON, Del., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), today announced its participation in the following investor conferences: CFO,
Clover Health to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
04:05pm, Tuesday, 18'th Feb 2025
WILMINGTON, Del., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), today announced that it will report fourth quarter and full year 2024 financi
Clover Health: Watch Out For Volatility Following Q4 Earnings Results
10:35am, Tuesday, 11'th Feb 2025
I remain bullish on Clover Health long-term but prefer to Hold until Q4 2024 earnings for higher conviction before initiating a long position in this stock. I believe the 40% YTD rise and 60% retail o
Clover Health Investments Is Building A Competitive Moat
03:42am, Tuesday, 21'st Jan 2025
Clover Health Investments, Corp. is a healthcare provider focused on providing Medicare Advantage plans to seniors. The company's proprietary AI technology helps drive higher reimbursement rates and l
Clover Health: Undervalued Turnaround Play With Promising SaaS Potential
11:24am, Thursday, 16'th Jan 2025
Clover Health's revenue rose 8% in Q3 2024, driven by a 7% growth in Medicare Advantage premiums, despite exiting low-margin ACO REACH program. Cost control measures are paying off, with salaries and
Focus On Costs, Regulatory Outlook For Health Insurers In Q4'24 Earnings Season
10:50am, Thursday, 16'th Jan 2025
Most publicly traded US health insurers are forecast to report sequential revenue and earnings declines for the fourth quarter of 2024, according to S&P Global Market Intelligence analysis of sell-sid
Clover Health Reports 27% Growth in Medicare Advantage Membership, Surpassing 100,000 Lives After Strong Annual Election Period
09:00am, Monday, 13'th Jan 2025
WILMINGTON, Del., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced a 27% year-over-year growt
